Dec 18, 2025 08:00AM
Dec 18, 2025 08:00AM
Nov 14, 2025 08:00AM
Sep 12, 2025 08:02AM
Sep 12, 2025 08:00AM
Sep 8, 2025 08:04AM
Sep 8, 2025 08:00AM Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
Aug 5, 2025 08:00AM
Aug 5, 2025 08:00AM
Jul 10, 2025 08:00AM
Jun 5, 2025 08:00AM
May 15, 2025 08:00AM
Apr 24, 2025 08:00AM
Mar 31, 2025 08:00AM Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Nov 13, 2024 08:00AM
Aug 14, 2024 08:00AM
Jun 20, 2024 08:00AM
May 14, 2024 08:45AM
May 13, 2024 08:00AM
May 1, 2024 08:00AM
Mar 28, 2024 08:00AM Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Mar 19, 2024 08:02AM
Mar 19, 2024 08:00AM
Nov 13, 2023 08:00AM
Aug 14, 2023 08:00AM
May 15, 2023 08:00AM
Mar 29, 2023 08:03AM
Mar 29, 2023 08:00AM Cocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programs
Nov 14, 2022 08:00AM
Nov 14, 2022 08:00AM
Aug 15, 2022 08:00AM
Aug 15, 2022 08:00AM
May 11, 2022 08:06AM
May 11, 2022 08:00AM
May 11, 2022 08:00AM Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
Mar 23, 2022 04:05PM
Mar 23, 2022 04:05PM
Mar 3, 2022 08:00AM
Mar 3, 2022 08:00AM
Jan 27, 2022 08:02AM
Jan 27, 2022 08:00AM
Jan 27, 2022 08:00AM Cocrystal Pharma Selects Two Lead Antiviral Drug Candidates for its COVID-19 Oral Drug Program
Jan 6, 2022 08:07AM
Jan 6, 2022 08:00AM
Jan 6, 2022 08:00AM
Jan 4, 2022 08:00AM
Jan 4, 2022 08:00AM
Dec 22, 2021 08:00AM
Dec 22, 2021 08:00AM Cocrystal Pharma’s COVID-19 Oral and Intranasal/Pulmonary Protease Inhibitors Exhibit Powerful In Vitro Potency Against the SARS-CoV-2 Omicron Variant
Dec 22, 2021 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All